Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model.
Article Details
- CitationCopy to clipboard
Cozzi PJ, Malhotra S, McAuliffe P, Kooby DA, Federoff HJ, Huryk B, Johnson P, Scardino PT, Heston WD, Fong Y
Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model.
FASEB J. 2001 May;15(7):1306-8.
- PubMed ID
- 11344122 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drugs